SCHEMBL7650700

SCHEMBL7650700

CCCCc1nc(C(c2ccncc2)c2ccc(-c3ccccc3C#N)cc2)n[nH]1

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.37
PDE3B Q13370 2/20 0.37
PDE3A Q14432 2/20 0.37
ACHE P22303 2/20 0.37
GSK3B P49841 2/20 0.36
GSK3A P49840 1/20 0.36
APLNR P35414 2/20 0.35
TRPA1 O75762 1/20 0.35
AGTR1 P30556 3/20 0.35
PDE10A Q9Y233 1/20 0.34
ESR2 Q92731 1/20 0.34
AGTR2 P50052 2/20 0.34
PIP4K2A P48426 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657853 0.93 PPARG (0.39) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7659925 0.90 ACHE (0.43) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7654069 0.87 APLNR (0.35) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7659480 0.86 ACHE (0.36) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7651418 0.86 PPARG (0.36) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7659947 0.82 ACHE (0.38) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL7650735 0.82 PPARG (0.39) PPARGACHEAPLNRTRPA1AGTR1
SCHEMBL8298258 0.70 AGTR1 (0.54) PPARGGSK3BGSK3AAGTR1AGTR2
SCHEMBL3460737 0.69 PPARG (0.40) PPARGACHEAPLNRAGTR1ESR2
SCHEMBL3459617 0.68 ACHE (0.40) PPARGACHEAPLNRAGTR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358984-B1 FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES LEAD CHEMICAL CO., LTD. (JP) 2002-03-19 US disclosed
US-6232335-B1 A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE LEAD CHEMICAL CO., LTD. (JP) 2001-05-15 US disclosed